As the conflict in Ukraine moves into its second month, efforts to provide essential medicines to those affected are continuing across the off-patent industry, with regional association Medicines for Europe urging additional action to allow the safe production and transportation of supplies.
One month on from the start of Russia’s invasion of Ukraine on 24 February, relief efforts are progressing across the off-patent industry as the conflict continues.
Regional generics and biosimilars association Medicines for Europe has highlighted that the supply of medicines is “critical yet unstable as...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
